Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01654107 · ClinicalTrials.gov registry record · Phase 1
Persistence-Targeted Smoking Cessation
A Phase 1 study of Tobacco Use Disorder, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 1
- Development phase
- 58
- Enrollment target
- 1
- Study location
NCT01654107: Completed Phase 1 study of Tobacco Use Disorder, sponsored by Rutgers, The State University of New Jersey.
NCT01654107 is a Phase 1 study of Tobacco Use Disorder that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 58 participants, below the 239-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01654107, a Phase 1 study of Tobacco Use Disorder, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 58 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose to develop a theory-based smoking cessation intervention (called Persistence-targeted smoking cessation; PTSC). PTSC includes 8 weekly individual counseling sessions and use of nicotine lozenge for 12 weeks. The investigators will test the feasibility and preliminary efficacy of the intervention (i.e., cigarettes per day and prolonged abstinence).
Primary Outcome
3-months after the Quit Date
Conditions Studied
Interventions
- DRUG Nicotine lozenge
- BEHAVIORAL Persistence Targeted Smoking Cessation
- BEHAVIORAL Clearing The Air
Study Locations (1)
New Jersey
- Rutgers Robert Wood Johnson Medical School - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-09 |
| Phase | Phase 1 |
What the finished NCT01654107 record still lists
NCT01654107 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 239-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Tobacco Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which Nicotine lozenge is the first listed.
NCT01654107 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT01654107 about?
NCT01654107 is a clinical study titled "Persistence-Targeted Smoking Cessation". The investigators propose to develop a theory-based smoking cessation intervention (called Persistence-targeted smoking cessation; PTSC). PTSC includes 8 weekly individual counseling sessions and use of nicotine lozenge for 12 weeks. The investigators will test the feasibility and preliminary effica...
What is the current status of trial NCT01654107?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 58 participants. The study started on 2012-07. Estimated completion is 2014-09.
What conditions does trial NCT01654107 study?
This clinical trial studies the following conditions: Tobacco Use Disorder.
What interventions are being tested in trial NCT01654107?
The interventions under investigation include: Nicotine lozenge (DRUG), Persistence Targeted Smoking Cessation (BEHAVIORAL), Clearing The Air (BEHAVIORAL).
Who is sponsoring clinical trial NCT01654107?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01654107 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01654107's enrollment target sits among peer trials
58 50th of 70 higher than 20 of 70 other Tobacco Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oral Cannabidiol for Tobacco Cessation
RECRUITING · Phase 1
-
Project 3, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in People With Current Affective Disorders
COMPLETED · Phase 1
-
Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3
COMPLETED · Phase 1
-
Lorcaserin for Preventing Weight Gain Among Smokers
COMPLETED · Phase 1
-
Brain Imaging in Tobacco Smokers During a Quit Attempt
COMPLETED · Phase 1
-
Project 2, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Opioid Abusers
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia